| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-04 18:53:52 UTC |
|---|
| Update Date | 2021-09-14 15:47:30 UTC |
|---|
| HMDB ID | HMDB0060705 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 12-Hydroxynevirapine glucuronide |
|---|
| Description | 12-Hydroxynevirapine glucuronide is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia) |
|---|
| Structure | CC1=C2N=C(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C3=C(N=CC=C3)N(C3CC3O)C2=NC=C1 InChI=1S/C21H22N4O8/c1-8-4-6-23-18-12(8)24-19(9-3-2-5-22-17(9)25(18)10-7-11(10)26)33-21-15(29)13(27)14(28)16(32-21)20(30)31/h2-6,10-11,13-16,21,26-29H,7H2,1H3,(H,30,31)/t10?,11?,13-,14-,15+,16-,21?/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C21H22N4O8 |
|---|
| Average Molecular Weight | 458.4214 |
|---|
| Monoisotopic Molecular Weight | 458.1437637 |
|---|
| IUPAC Name | (2S,3S,4S,5R)-3,4,5-trihydroxy-6-{[2-(2-hydroxycyclopropyl)-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaen-10-yl]oxy}oxane-2-carboxylic acid |
|---|
| Traditional Name | (2S,3S,4S,5R)-3,4,5-trihydroxy-6-{[2-(2-hydroxycyclopropyl)-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaen-10-yl]oxy}oxane-2-carboxylic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C2N=C(OC3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C3=C(N=CC=C3)N(C3CC3O)C2=NC=C1 |
|---|
| InChI Identifier | InChI=1S/C21H22N4O8/c1-8-4-6-23-18-12(8)24-19(9-3-2-5-22-17(9)25(18)10-7-11(10)26)33-21-15(29)13(27)14(28)16(32-21)20(30)31/h2-6,10-11,13-16,21,26-29H,7H2,1H3,(H,30,31)/t10?,11?,13-,14-,15+,16-,21?/m0/s1 |
|---|
| InChI Key | UVZMQJUCOZEMQZ-RDPCRGLVSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as o-glucuronides. These are glucuronides in which the aglycone is linked to the carbohydrate unit through an O-glycosidic bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | O-glucuronides |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1-o-glucuronide
- O-glucuronide
- Alkyldiarylamine
- Glycosyl compound
- O-glycosyl compound
- Pyrido-para-diazepine
- Beta-hydroxy acid
- Methylpyridine
- Hydroxy acid
- Monosaccharide
- Oxane
- Pyran
- Pyridine
- Imidolactone
- Imidolactam
- Heteroaromatic compound
- Secondary alcohol
- Cyclopropanol
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid
- Carboxylic acid derivative
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Oxacycle
- Acetal
- Polyol
- Monocarboxylic acid or derivatives
- Organopnictogen compound
- Alcohol
- Organic oxide
- Hydrocarbon derivative
- Organic nitrogen compound
- Organonitrogen compound
- Carbonyl group
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.31 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.6782 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.88 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 562.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 188.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 81.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 158.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 54.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 282.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 333.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 506.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 595.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 64.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 895.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 195.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 222.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 469.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 249.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 338.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 12-Hydroxynevirapine glucuronide,1TMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3801.4 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TMS,isomer #2 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3803.7 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TMS,isomer #3 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3811.6 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TMS,isomer #4 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3715.5 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TMS,isomer #5 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3787.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3679.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #10 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3655.2 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #2 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3717.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #3 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3724.0 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #4 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3694.1 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #5 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3676.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #6 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3737.0 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #7 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3693.6 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #8 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3679.7 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TMS,isomer #9 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3698.6 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3648.5 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #10 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3630.4 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #2 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3657.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #3 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3632.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #4 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3703.9 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #5 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3647.9 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #6 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3659.2 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #7 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3661.2 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #8 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3607.5 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TMS,isomer #9 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3668.6 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,4TMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O | 3661.7 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,4TMS,isomer #2 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3606.2 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,4TMS,isomer #3 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3617.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,4TMS,isomer #4 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3654.5 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,4TMS,isomer #5 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3616.2 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,5TMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C | 3642.4 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TBDMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3931.1 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TBDMS,isomer #2 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3942.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TBDMS,isomer #3 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O | 3942.5 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TBDMS,isomer #4 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3919.0 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,1TBDMS,isomer #5 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 3949.4 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3980.2 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #10 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 3971.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #2 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3976.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #3 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O | 3987.6 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #4 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 3976.9 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #5 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 3972.7 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #6 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O | 4002.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #7 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 3986.0 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #8 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O | 3991.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,2TBDMS,isomer #9 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 3986.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #1 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O | 4029.8 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #10 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 4047.5 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #2 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O | 4057.1 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #3 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 4030.0 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #4 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O | 4056.7 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #5 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 4017.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #6 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 4030.3 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #7 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O | 4054.0 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #8 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 4012.7 | Semi standard non polar | 33892256 | | 12-Hydroxynevirapine glucuronide,3TBDMS,isomer #9 | CC1=CC=NC2=C1N=C(OC1O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]1O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC1O[Si](C)(C)C(C)(C)C | 4042.8 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 12-Hydroxynevirapine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-054o-9316800000-d96dd4aace090a4e7ee9 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 12-Hydroxynevirapine glucuronide GC-MS (3 TMS) - 70eV, Positive | splash10-0a4r-5261049000-d43cc6f3459aa48de843 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 12-Hydroxynevirapine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 10V, Positive-QTOF | splash10-0006-0030900000-500d28d5628f38d3c6c6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 20V, Positive-QTOF | splash10-014i-0190100000-88665b3063b67868de3b | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 40V, Positive-QTOF | splash10-0aor-3090000000-905144dc1d7153e1ff49 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 10V, Negative-QTOF | splash10-0bt9-1121900000-e12fed92493fe1b0bee6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 20V, Negative-QTOF | splash10-0gzj-6747900000-d15a990f677806f2cbba | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 40V, Negative-QTOF | splash10-001i-6390000000-0152d71f8d201776e7d0 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 10V, Negative-QTOF | splash10-0a4i-0010900000-d3e1b5e96cf801634eaf | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 20V, Negative-QTOF | splash10-0bu0-0193400000-b7ac734a047a666f2a6c | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 40V, Negative-QTOF | splash10-00di-1090100000-446733a22017a4c98c44 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 10V, Positive-QTOF | splash10-06r6-0200900000-a99d3af66ea75f78a584 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 20V, Positive-QTOF | splash10-06sl-0138900000-58ec7d4873e225760587 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 12-Hydroxynevirapine glucuronide 40V, Positive-QTOF | splash10-004i-1291000000-3644b9c53a78fe4b3efe | 2021-10-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|